Synlogic Inc SYBX:NASDAQ

Last Price$1.33Cboe Closing Price as of 4:01PM ET 5/20/22
Cboe Real-Time Quotes
Today's Change+0.12(9.92%)
Bid (Size)$1.23 (100)
Ask (Size)$1.61 (100)
Day Low / High$1.16 - 1.44
Volume681.4 K
 

View Biotechnology IndustryPeer Comparison as of 05/20/2022

 

Synlogic Inc ( NASDAQ )

Price: $1.33
Change: +0.12 (9.92%)
Volume: 681.4 K
4:01PM ET 5/20/2022
 
 

Adverum Biotechnologies Inc ( NASDAQ )

Price: $0.86
Change: +0.004 (0.47%)
Volume: 711.9 K
4:01PM ET 5/20/2022
 
 

Magenta Therapeutics Inc ( NASDAQ )

Price: $1.22
Change: -0.24 (16.78%)
Volume: 493.4 K
4:01PM ET 5/20/2022
 
 

Epizyme Inc ( NASDAQ )

Price: $0.52
Change: -0.002 (0.46%)
Volume: 1.1 M
3:54PM ET 5/20/2022
 
 

Equillium Inc ( NASDAQ )

Price: $2.52
Change: -0.01 (0.40%)
Volume: 19.1 K
3:53PM ET 5/20/2022
 

Read more news Recent News

--Chardan Lowers Synlogic's Price Target to $9 From $10, Maintains Buy Rating
10:55AM ET 5/13/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Chardan Research Trims Synlogic's Price Target to $9 From $10, Citing Commercialization Timelines; Buy Rating Kept
4:45AM ET 5/13/2022 MT Newswires

Synlogic (SYBX) has an average rating of buy and price targets ranging from $6 to $9, according to analysts polled by Capital IQ. (MT Newswires covers...

-- Earnings Flash (SYBX) SYNLOGIC Reports Q1 Revenue $244,000, vs. Street Est of $0.16M
7:05AM ET 5/12/2022 MT Newswires

...

--SVB Leerink Adjusts Synlogic's Price Target to $8 from $11, Keeps Outperform Rating
8:57AM ET 3/18/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionSynlogic, Inc. engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on August 28, 2017, and is headquartered in Cambridge, MA. View company web site for more details
Address301 Binney Street
Cambridge, Massachusetts 02142
Phone+1.617.401.9975
Number of Employees74
President, Chief Executive Officer & DirectorAoife M. Brennan
Chief Operating OfficerAntoine Awad
Chief Financial OfficerMichael Jensen
Chief Scientific OfficerDavid L. Hava

Company Highlights

Price Open$1.20
Previous Close$1.21
52 Week Range$1.02 - 4.54
Market Capitalization$93.4 M
Shares Outstanding70.3 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.14
Beta vs. S&P 500N/A
Revenue$2.5 M
Net Profit Margin-3,452.74%
Return on Equity-44.37%

Analyst Ratings as of 12/10/2021

Buy
5
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset